AI news
Danaher plans an AI-powered antibody research lab for 2027
Danaher announced plans for an autonomous lab at its Abcam business combining AI, robotics and instruments to design and test research antibodies. It expects the lab to operate at scale in early 2027. Claimed eightfold speed and tenfold output are projected design targets, not measured outcomes from a live scaled lab.
Primary source · Danaher · October 7, 2026
Opens Danaher in a new tab. Read it there before you rely on the summary above.
Read the original
Free, email only
Unlock the full brief free.
- What to check before you trust this story, written down
- Each verified source, with why it matters and who published it
- A note whenever a source has been withdrawn
- Thirty days of stories to browse, not seven
